Compounders Research Compare

Adial Pharmaceuticals, Inc.(ADIL)

Biotechnology · Glen Allen, VA

$4.27-0.08 (-1.84%)

Delayed quote: Oct 6, 2026, 10:52 AM EDT

About Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.

Glen Allen, VA

5 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Cary John Claiborne

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T14:55:38.202Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:55:38.202Z.

Quote observation: 2026-10-06T14:52:28.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -16.53
Quote price: 4.27

FMP input reference: fa223cd5a0006a47bd3f11d3634c651a1c818c2f8beb58cb941cded2cdd6eca8

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ADIL Earnings Yield Metrics

EARNINGS YIELD

N/A

ADIL Competitors' Earnings Yield

Adial Pharmaceuticals, Inc.

Current

Market Cap

$11.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Kiora Pharmaceuticals, Inc.

Market Cap

$11.26M

Earnings Yield

N/A

TTM Avg

44.71%

3Y Avg

44.71%

5Y Avg

44.71%

Biofrontera Inc.

Market Cap

$11.14M

Earnings Yield

N/A

TTM Avg

10.43%

3Y Avg

10.43%

5Y Avg

10.43%

Bullfrog AI Holdings, Inc. Common Stock

Market Cap

$11.46M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lisata Therapeutics, Inc.

Market Cap

$11.38M

Earnings Yield

N/A

TTM Avg

53.42%

3Y Avg

53.42%

5Y Avg

53.42%

BioVie Inc.

Market Cap

$11.16M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CytoMed Therapeutics Limited

Market Cap

$11.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cerenome, Inc.

Market Cap

$10.81M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lifeward Ltd.

Market Cap

$10.47M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Satellos Bioscience Inc.

Market Cap

$10.42M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Adial Pharmaceuticals, Inc. (ADIL)	$11.21M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.26M	N/A	44.71%	44.71%	44.71%
Biofrontera Inc. (BFRI)vs ›	$11.14M	N/A	10.43%	10.43%	10.43%
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$11.46M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.38M	N/A	53.42%	53.42%	53.42%
BioVie Inc. (BIVI)vs ›	$11.16M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$11.24M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.81M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.47M	N/A	N/A	N/A	N/A
Satellos Bioscience Inc. (MSLE)vs ›	$10.42M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics